Communicators

are winners!

More News

25.02.2025

Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile

22.02.2025

Onco-Innovations Provides Information Regarding Inka Health’s USPTO Provisional Patent Application for AI-Powered Precision Medicine Platform, SynoGraph

15.02.2025

Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth

11.02.2025

Onco-Innovations’ Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study

07.02.2025

Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research

04.02.2025

Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development

30.01.2025

Onco-Innovations’ Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair

29.01.2025

Onco-Innovations’ Private Placement Fully Subscribed

23.01.2025

Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development

16.01.2025

Onco-Innovations’ Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells